Dianthus Therapeutics Statistics

Total Valuation

DNTH has a market cap or net worth of $642.18 million. The enterprise value is $286.70 million.

Market Cap	642.18M
Enterprise Value	286.70M

Important Dates

The last earnings date was Tuesday, March 11, 2025, after market close.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

DNTH has 32.13 million shares outstanding. The number of shares has increased by 546.44% in one year.

Current Share Class	32.13M
Shares Outstanding	32.13M
Shares Change (YoY)	+546.44%
Shares Change (QoQ)	+2.33%
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	70.51%
Float	14.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	106.81
Forward PS	180.42
PB Ratio	1.76
P/TBV Ratio	1.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	45.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.22, with a Debt / Equity ratio of 0.00.

Current Ratio	15.22
Quick Ratio	14.96
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.60% and return on invested capital (ROIC) is -24.33%.

Return on Equity (ROE)	-32.60%
Return on Assets (ROA)	-23.01%
Return on Invested Capital (ROIC)	-24.33%
Return on Capital Employed (ROCE)	-28.65%
Revenue Per Employee	$79,936
Profits Per Employee	-$1.09M
Employee Count	78
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.67%
50-Day Moving Average	21.81
200-Day Moving Average	25.30
Relative Strength Index (RSI)	44.36
Average Volume (20 Days)	375,156

Short Selling Information

The latest short interest is 5.57 million, so 17.34% of the outstanding shares have been sold short.

Short Interest	5.57M
Short Previous Month	5.42M
Short % of Shares Out	17.34%
Short % of Float	39.46%
Short Ratio (days to cover)	22.90

Income Statement

In the last 12 months, DNTH had revenue of $6.24 million and -$84.97 million in losses. Loss per share was -$2.55.

Revenue	6.24M
Gross Profit	6.24M
Operating Income	-101.86M
Pretax Income	-56.68M
Net Income	-84.97M
EBITDA	-101.77M
EBIT	-101.86M
Loss Per Share	-$2.55

Full Income Statement

Balance Sheet

The company has $275.24 million in cash and $1.49 million in debt, giving a net cash position of $355.48 million or $11.07 per share.

Cash & Cash Equivalents	275.24M
Total Debt	1.49M
Net Cash	355.48M
Net Cash Per Share	$11.07
Equity (Book Value)	352.48M
Book Value Per Share	11.33
Working Capital	262.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$78.18 million and capital expenditures -$105,000, giving a free cash flow of -$78.29 million.

Operating Cash Flow	-78.18M
Capital Expenditures	-105,000
Free Cash Flow	-78.29M
FCF Per Share	-$2.44

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,633.74%
Pretax Margin	-1,362.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DNTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-546.44%
Shareholder Yield	n/a
Earnings Yield	-13.23%
FCF Yield	-12.19%

Analyst Forecast

The average price target for DNTH is $54.33, which is 171.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$54.33
Price Target Difference	171.79%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	6.40%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DNTH has an Altman Z-Score of 19.36 and a Piotroski F-Score of 2.

Altman Z-Score	19.36
Piotroski F-Score	2